ARTICLE | Clinical News
North American Vaccine regulatory update
April 15, 2013 7:00 AM UTC
NVX received Swedish approval for its monovalent acellular pertussis (aP) vaccine to vaccinate children against pertussis (whooping cough). The company said the approval expands the indication in Swed...